These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 17028370)

  • 21. ADHD risk genes involved in dopamine signaling and metabolism are associated with reduced estimated life expectancy at young adult follow-up in hyperactive and control children.
    Barkley RA; Smith KM; Fischer M
    Am J Med Genet B Neuropsychiatr Genet; 2019 Apr; 180(3):175-185. PubMed ID: 30637915
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dissecting the attention deficit hyperactivity disorder (ADHD) phenotype: sustained attention, response variability and spatial attentional asymmetries in relation to dopamine transporter (DAT1) genotype.
    Bellgrove MA; Hawi Z; Kirley A; Gill M; Robertson IH
    Neuropsychologia; 2005; 43(13):1847-57. PubMed ID: 16168728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An association between a dopamine transporter gene (SLC6A3) haplotype and ADHD symptom measures in nonclinical adults.
    Tong JH; Cummins TD; Johnson BP; McKinley LA; Pickering HE; Fanning P; Stefanac NR; Newman DP; Hawi Z; Bellgrove MA
    Am J Med Genet B Neuropsychiatr Genet; 2015 Mar; 168B(2):89-96. PubMed ID: 25656223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relations between multi-informant assessments of ADHD symptoms, DAT1, and DRD4.
    Gizer IR; Waldman ID; Abramowitz A; Barr CL; Feng Y; Wigg KG; Misener VL; Rowe DC
    J Abnorm Psychol; 2008 Nov; 117(4):869-80. PubMed ID: 19025233
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Candidate gene studies of attention-deficit/hyperactivity disorder.
    Faraone SV; Khan SA
    J Clin Psychiatry; 2006; 67 Suppl 8():13-20. PubMed ID: 16961425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DAT1 and DRD4 genes involved in key dimensions of adult ADHD.
    Hasler R; Salzmann A; Bolzan T; Zimmermann J; Baud P; Giannakopoulos P; Perroud N
    Neurol Sci; 2015 Jun; 36(6):861-9. PubMed ID: 25555995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Attention-deficit hyperactivity disorder in adults: A systematic review and meta-analysis of genetic, pharmacogenetic and biochemical studies.
    Bonvicini C; Faraone SV; Scassellati C
    Mol Psychiatry; 2016 Jul; 21(7):872-84. PubMed ID: 27217152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Understanding genes, environment and their interaction in attention-deficit hyperactivity disorder: is there a role for neuroimaging?
    Plomp E; Van Engeland H; Durston S
    Neuroscience; 2009 Nov; 164(1):230-40. PubMed ID: 19619618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic associations between ADHD and dopaminergic genes (DAT1 and DRD4) VNTRs in Korean children.
    Hong JH; Hwang IW; Lim MH; Kwon HJ; Jin HJ
    Genes Genomics; 2018 Dec; 40(12):1309-1317. PubMed ID: 30099719
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The analysis of 51 genes in DSM-IV combined type attention deficit hyperactivity disorder: association signals in DRD4, DAT1 and 16 other genes.
    Brookes K; Xu X; Chen W; Zhou K; Neale B; Lowe N; Anney R; Franke B; Gill M; Ebstein R; Buitelaar J; Sham P; Campbell D; Knight J; Andreou P; Altink M; Arnold R; Boer F; Buschgens C; Butler L; Christiansen H; Feldman L; Fleischman K; Fliers E; Howe-Forbes R; Goldfarb A; Heise A; Gabriëls I; Korn-Lubetzki I; Johansson L; Marco R; Medad S; Minderaa R; Mulas F; Müller U; Mulligan A; Rabin K; Rommelse N; Sethna V; Sorohan J; Uebel H; Psychogiou L; Weeks A; Barrett R; Craig I; Banaschewski T; Sonuga-Barke E; Eisenberg J; Kuntsi J; Manor I; McGuffin P; Miranda A; Oades RD; Plomin R; Roeyers H; Rothenberger A; Sergeant J; Steinhausen HC; Taylor E; Thompson M; Faraone SV; Asherson P
    Mol Psychiatry; 2006 Oct; 11(10):934-53. PubMed ID: 16894395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Genomic endophenotypes of attention deficit hyperactivity disorder].
    Fernández-Jaén A; Fernández-Mayoralas DM; Calleja-Pérez B; Muñoz-Jareño N; López-Arribas S
    Rev Neurol; 2012 Feb; 54 Suppl 1():S81-7. PubMed ID: 22374776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of the dopamine transporter gene on striatal functional connectivity in youths with attention-deficit/hyperactivity disorder.
    Shang CY; Lin HY; Gau SS
    Psychol Med; 2021 Apr; 51(5):835-845. PubMed ID: 31907092
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brain perfusion and dopaminergic genes in boys with attention-deficit/hyperactivity disorder.
    Szobot C; Roman T; Cunha R; Acton P; Hutz M; Rohde LA
    Am J Med Genet B Neuropsychiatr Genet; 2005 Jan; 132B(1):53-8. PubMed ID: 15389753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DAT1 methylation is associated with methylphenidate response on oppositional and hyperactive-impulsive symptoms in children and adolescents with ADHD.
    Ding K; Yang J; Reynolds GP; Chen B; Shao J; Liu R; Qian Q; Liu H; Yang R; Wen J; Kang C
    World J Biol Psychiatry; 2017 Jun; 18(4):291-299. PubMed ID: 27676100
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of the dopamine transporter (DAT1) 10/10-repeat genotype with ADHD symptoms and response inhibition in a general population sample.
    Cornish KM; Manly T; Savage R; Swanson J; Morisano D; Butler N; Grant C; Cross G; Bentley L; Hollis CP
    Mol Psychiatry; 2005 Jul; 10(7):686-98. PubMed ID: 15809660
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Meta-analysis shows significant association between dopamine system genes and attention deficit hyperactivity disorder (ADHD).
    Li D; Sham PC; Owen MJ; He L
    Hum Mol Genet; 2006 Jul; 15(14):2276-84. PubMed ID: 16774975
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dopamine transporter gene polymorphism moderates the effects of severe deprivation on ADHD symptoms: developmental continuities in gene-environment interplay.
    Stevens SE; Kumsta R; Kreppner JM; Brookes KJ; Rutter M; Sonuga-Barke EJ
    Am J Med Genet B Neuropsychiatr Genet; 2009 Sep; 150B(6):753-61. PubMed ID: 19655343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of dopamine, serotonin, and nicotinic gene polymorphisms with methylphenidate response in ADHD.
    Tharoor H; Lobos EA; Todd RD; Reiersen AM
    Am J Med Genet B Neuropsychiatr Genet; 2008 Jun; 147B(4):527-30. PubMed ID: 17948872
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High sibling correlation on methylphenidate response but no association with DAT1-10R homozygosity in Dutch sibpairs with ADHD.
    van der Meulen EM; Bakker SC; Pauls DL; Oteman N; Kruitwagen CL; Pearson PL; Sinke RJ; Buitelaar JK
    J Child Psychol Psychiatry; 2005 Oct; 46(10):1074-80. PubMed ID: 16178931
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular imaging genetics of methylphenidate response in ADHD and substance use comorbidity.
    Szobot CM; Roman T; Hutz MH; Genro JP; Shih MC; Hoexter MQ; Júnior N; Pechansky F; Bressan RA; Rohde LA
    Synapse; 2011 Feb; 65(2):154-9. PubMed ID: 20593420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.